Literature DB >> 12069135

Intracranial dural arteriovenous malformations: results of stereotactic radiosurgery in 17 patients.

Suzanne O'Leary1, Timothy J Hodgson, Stuart C Coley, Andreas A Kemeny, Matthias W R Radatz.   

Abstract

AIM: To assess the efficacy of stereotactic radiosurgery (STRS) for the treatment of dural arteriovenous fistulae (DAVF).
MATERIALS AND METHODS: Between November 1987 and December 1998, 17 patients with a total of 18 DAVF were treated with STRS at the National Centre for Stereotactic Radiosurgery, Sheffield. Clinical and radiological data was collected retrospectively from the case notes and radiological records. Two neuroradiologists classified the pre-STRS appearance of the DAVF using the Borden criteria, and reviewed the follow-up imaging. Up to date follow-up was requested from the GPs and referring consultants.
RESULTS: In retrospect one DAVF had been misdiagnosed and was excluded from the study. The remaining 17 DAVF were located at the tentorium (6), cavernous sinus (3), right parasellar region (1), floor of left middle cranial fossa (1), midline posterior fossa (1), petrous apex (1) and transverse sinus (4). Ten were Borden type I, four were type II, three were type III. Follow-up angiography was available for 13 patients; 10 DAVF were completely obliterated, two showed considerable reduction in size, one showed deterioration. Clinical follow-up was available for 14 of the 16 patients.
CONCLUSION: Stereotactic radiosurgery can successfully obliterate DAVF with few side effects.

Entities:  

Mesh:

Year:  2002        PMID: 12069135     DOI: 10.1053/clon.2002.0072

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  10 in total

1.  Bilateral petrous ridge dural arteriovenous malformations treated by a combination of endovascular embolization and surgical excision. A case report.

Authors:  S O Seong; C David; In Sup Choi
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

Review 2.  Radiosurgery for intracranial dural arteriovenous fistulas (DAVFs): a review.

Authors:  Ioannis Loumiotis; Giuseppe Lanzino; David Daniels; Jason Sheehan; Michael Link
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

3.  MR imaging findings of intracranial dural arteriovenous fistulas: relations with venous drainage patterns.

Authors:  Bae Ju Kwon; Moon Hee Han; Hyun-Seung Kang; Kee-Hyun Chang
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

4.  Treatment Strategy Based on Multimodal Management Outcome of Cavernous Sinus Dural Arteriovenous Fistula (CSDAVF).

Authors:  Byung Se Choi; Jee Won Park; Jong Lim Kim; Sung Youn Kim; Yang Shin Park; Heon-Ju Kwon; Deok Hee Lee; Dae Chul Suh
Journal:  Neurointervention       Date:  2011-02-28

5.  Endovascular management of dural arteriovenous fistulas of the transverse and sigmoid sinus in 150 patients.

Authors:  M Kirsch; T Liebig; D Kühne; H Henkes
Journal:  Neuroradiology       Date:  2009-04-08       Impact factor: 2.804

6.  Treatment of dural arteriovenous fistulas.

Authors:  Vasilios Katsaridis
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

7.  Paradoxical exacerbation of symptoms with obstruction of the venous outflow after gamma knife radiosurgery for treatment of a dural arteriovenous fistula of the cavernous sinus.

Authors:  Jun Kyeung Ko; Won Ho Cho; Tae Hong Lee; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2015-02-26

8.  Intracranial dural arteriovenous fistulas: A Review.

Authors:  Ak Gupta; Al Periakaruppan
Journal:  Indian J Radiol Imaging       Date:  2009-02

9.  Intractable Posterior Epistaxis due to a Spontaneous Low-Flow Carotid-Cavernous Sinus Fistula: A Case Report and a Review of the Literature.

Authors:  A Giotakis; F Kral; H Riechelmann; M Freund
Journal:  Case Rep Otolaryngol       Date:  2015-12-29

Review 10.  Endovascular treatment for dural arteriovenous fistulas in the petroclival region.

Authors:  Kun Hou; Xianli Lv; Lai Qu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.